CO6680670A2 - Agonistas de ep4 prostaglandina útiles en la preparación de lal piel y la cicatrización de heridas - Google Patents
Agonistas de ep4 prostaglandina útiles en la preparación de lal piel y la cicatrización de heridasInfo
- Publication number
- CO6680670A2 CO6680670A2 CO13038986A CO13038986A CO6680670A2 CO 6680670 A2 CO6680670 A2 CO 6680670A2 CO 13038986 A CO13038986 A CO 13038986A CO 13038986 A CO13038986 A CO 13038986A CO 6680670 A2 CO6680670 A2 CO 6680670A2
- Authority
- CO
- Colombia
- Prior art keywords
- wound healing
- skin preparation
- agonists useful
- prostaglandin agonists
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cosmetics (AREA)
Abstract
La descripción proporciona composiciones y métodos para tratar un defecto de la piel. Las composiciones comprenden una cantidad terapéuticamente eficaz de un compuesto útil para el tratamiento de defectos de la piel tales como heridas, cicatrices y arrugas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36923210P | 2010-07-30 | 2010-07-30 | |
US41911510P | 2010-12-02 | 2010-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6680670A2 true CO6680670A2 (es) | 2013-05-31 |
Family
ID=44543791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13038986A CO6680670A2 (es) | 2010-07-30 | 2013-02-26 | Agonistas de ep4 prostaglandina útiles en la preparación de lal piel y la cicatrización de heridas |
Country Status (17)
Country | Link |
---|---|
US (1) | US20120136011A1 (es) |
EP (1) | EP2598140B1 (es) |
JP (1) | JP2013536183A (es) |
KR (1) | KR20130130694A (es) |
CN (1) | CN103068382A (es) |
AR (1) | AR082428A1 (es) |
AU (1) | AU2011282549A1 (es) |
BR (1) | BR112013002319A2 (es) |
CA (1) | CA2806982A1 (es) |
CL (1) | CL2013000308A1 (es) |
CO (1) | CO6680670A2 (es) |
MX (1) | MX2013001227A (es) |
NZ (1) | NZ607306A (es) |
RU (1) | RU2013108394A (es) |
SG (1) | SG187653A1 (es) |
TW (1) | TW201210601A (es) |
WO (1) | WO2012016109A2 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8697458B2 (en) | 2009-04-22 | 2014-04-15 | Shat-R-Shield, Inc. | Silicone coated light-emitting diode |
US8894992B2 (en) * | 2010-08-19 | 2014-11-25 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8741281B2 (en) * | 2010-08-19 | 2014-06-03 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) * | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
WO2012024072A1 (en) * | 2010-08-19 | 2012-02-23 | Allergan, Inc. | Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition |
US8889123B2 (en) * | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8900571B2 (en) * | 2010-08-19 | 2014-12-02 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8697057B2 (en) * | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8883139B2 (en) * | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US8926963B2 (en) * | 2010-08-19 | 2015-01-06 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US20120142684A1 (en) * | 2010-12-02 | 2012-06-07 | Allergan, Inc. | Compounds and methods for skin repair |
CA2891595A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Compounds and methods for skin repair |
WO2014078446A2 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations |
CN105579438B (zh) * | 2013-09-27 | 2019-12-06 | 阿勒根公司 | 用于皮肤修复的化合物和方法 |
RU2625548C1 (ru) * | 2015-04-29 | 2017-07-14 | Жанна Юрьевна Юсова | Способ коррекции возрастных изменений кожи лица |
TWI593403B (zh) * | 2016-12-01 | 2017-08-01 | yi-ting Xu | Remedial repair of facial damage |
RU2663391C1 (ru) * | 2018-01-30 | 2018-08-03 | Игорь Николаевич Бондаренко | Способ эстетической коррекции мягких тканей лица |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
TWI249520B (en) * | 1998-07-15 | 2006-02-21 | Ono Pharmaceutical Co | 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient |
US6586468B1 (en) * | 1998-09-14 | 2003-07-01 | Ono Pharmaceutical Co., Ltd. | ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient |
JP4618548B2 (ja) * | 1999-11-24 | 2011-01-26 | 小野薬品工業株式会社 | 骨量低下疾患治療剤 |
HU230421B1 (hu) * | 2001-07-23 | 2016-05-30 | Ono Pharmaceutical Co., Ltd | Csonttömegveszteséggel kapcsolatos betegségek kezelésére adható, EP4 agonistát tartalmazó gyógyászati készítmények és hatóanyagként alkalmazható vegyületek |
US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
EP1563846B1 (en) * | 2002-10-10 | 2012-08-29 | Ono Pharmaceutical Co., Ltd. | Endogenous repair factor production promoters |
US6875787B2 (en) | 2003-02-11 | 2005-04-05 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
US7855226B2 (en) * | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
WO2004071428A2 (en) * | 2003-02-11 | 2004-08-26 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
JPWO2006016695A1 (ja) * | 2004-08-10 | 2008-05-01 | 小野薬品工業株式会社 | Ep4アゴニストを含有してなる高カリウム血症の予防および/または治療剤 |
JP2006321737A (ja) * | 2005-05-18 | 2006-11-30 | Ono Pharmaceut Co Ltd | Ep4アゴニストを含有する神経変性疾患の予防、治療および/または進展抑制剤 |
JP2007023028A (ja) * | 2005-06-16 | 2007-02-01 | Ono Pharmaceut Co Ltd | 内耳疾患治療剤 |
US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
US7439372B2 (en) * | 2006-05-03 | 2008-10-21 | Allergan, Inc. | Therapeutic compounds |
KR20090089868A (ko) * | 2006-12-15 | 2009-08-24 | 글락소 그룹 리미티드 | Ep4 수용체 작동제로서 벤즈아미드 유도체 |
AU2007334038A1 (en) * | 2006-12-18 | 2008-06-26 | Allergan, Inc. | Methods and compositions for treating gastrointestinal disorders |
WO2008136519A1 (ja) * | 2007-05-08 | 2008-11-13 | National University Corporation, Hamamatsu University School Of Medicine | Ep4アゴニストを含有してなる細胞傷害性t細胞の活性化剤 |
GB0810615D0 (en) * | 2008-06-10 | 2008-07-16 | Glaxo Group Ltd | Novel pharmaceutical |
-
2011
- 2011-07-29 MX MX2013001227A patent/MX2013001227A/es not_active Application Discontinuation
- 2011-07-29 AU AU2011282549A patent/AU2011282549A1/en not_active Abandoned
- 2011-07-29 NZ NZ60730611A patent/NZ607306A/en unknown
- 2011-07-29 CA CA2806982A patent/CA2806982A1/en not_active Abandoned
- 2011-07-29 JP JP2013523219A patent/JP2013536183A/ja active Pending
- 2011-07-29 US US13/194,078 patent/US20120136011A1/en not_active Abandoned
- 2011-07-29 SG SG2013007430A patent/SG187653A1/en unknown
- 2011-07-29 EP EP11744157.6A patent/EP2598140B1/en active Active
- 2011-07-29 TW TW100127126A patent/TW201210601A/zh unknown
- 2011-07-29 WO PCT/US2011/045833 patent/WO2012016109A2/en active Application Filing
- 2011-07-29 KR KR1020137004837A patent/KR20130130694A/ko not_active Application Discontinuation
- 2011-07-29 AR ARP110102761A patent/AR082428A1/es unknown
- 2011-07-29 BR BR112013002319A patent/BR112013002319A2/pt not_active IP Right Cessation
- 2011-07-29 CN CN2011800404387A patent/CN103068382A/zh active Pending
- 2011-07-29 RU RU2013108394/15A patent/RU2013108394A/ru not_active Application Discontinuation
-
2013
- 2013-01-30 CL CL2013000308A patent/CL2013000308A1/es unknown
- 2013-02-26 CO CO13038986A patent/CO6680670A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR082428A1 (es) | 2012-12-05 |
NZ607306A (en) | 2015-03-27 |
CL2013000308A1 (es) | 2013-04-12 |
EP2598140B1 (en) | 2015-01-14 |
KR20130130694A (ko) | 2013-12-02 |
SG187653A1 (en) | 2013-03-28 |
BR112013002319A2 (pt) | 2016-05-24 |
JP2013536183A (ja) | 2013-09-19 |
MX2013001227A (es) | 2013-04-24 |
WO2012016109A3 (en) | 2012-03-22 |
AU2011282549A1 (en) | 2013-02-28 |
CN103068382A (zh) | 2013-04-24 |
CA2806982A1 (en) | 2012-02-02 |
EP2598140A2 (en) | 2013-06-05 |
US20120136011A1 (en) | 2012-05-31 |
WO2012016109A2 (en) | 2012-02-02 |
TW201210601A (en) | 2012-03-16 |
RU2013108394A (ru) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6680670A2 (es) | Agonistas de ep4 prostaglandina útiles en la preparación de lal piel y la cicatrización de heridas | |
EP3884931A3 (en) | Multi-layer biomaterial for tissue regeneration and wound healing | |
ECSP19025350A (es) | Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi) | |
DOP2010000282A (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa | |
CR20130356A (es) | Dispositivos y metodos para tratamiento de heridas o de la piel | |
BR112014000775A2 (pt) | curativo de ferimento e método de tratamento | |
CL2013001579A1 (es) | Uso de una composicion farmaceutica que comprende un compuesto agonista ep4 para tratar marcas de la piel tales como heridas superficiales, cicatrices o arrugas. | |
BR112012028451A2 (pt) | composição tópica de iodopovidona | |
PE20180780A1 (es) | Composicion y productos que comprenden celulas senescentes para su uso en la regeneracion de tejidos | |
BR112012030261A2 (pt) | nova composição farmacêutica sinergística para a preparação de formulações tópicas para a pofilaxia e tratamento de feridas, feridas por queimaduras, exertos de pele, úlceras de pressão e úlceras do pé diabético | |
RU2017127273A (ru) | Короткие антимикробные липопептиды | |
CO7240418A2 (es) | Apósito con una liberación prolongada de agentes activos | |
EA201592073A1 (ru) | Фармацевтические композиции, содержащие коллаген и гиалуронат натрия | |
CL2015000254A1 (es) | Vesículas que comprenden factor de crecimiento epidermico (egf); proceso de preparación; composición farmacéutica que las comprende; y uso para tratar heridas complejas . | |
PH12015502405B1 (en) | Methods and compositions for wound healing | |
EA201690854A1 (ru) | Фармацевтические композиции с гидратирующим и смазывающим действием | |
UY34096A (es) | Soporte de colageno enrollado | |
EA201490209A1 (ru) | Лечение избыточного менструального кровотечения, обусловленного фибромой матки | |
MX2015015379A (es) | Agonistas alfa adrenergicos para el tratamiento de traumatismo de tejidos. | |
BR112012029747A2 (pt) | composição de tratamento da pele, método para fornecer um efeito antimicrobiano para a pele e utilização de uma composição | |
EA201071350A1 (ru) | Композиции и способы для лечения воспаления роговицы | |
UA54173U (ru) | Способ асептизации раневых поверхностей у ж | |
TR201202703U (tr) | Yaralarda nekrotik doku temizleme örtüsü. | |
RU2009123950A (ru) | Способ лечения гнойных кожно-мышечных ран у животных | |
CU20100183A7 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |